cellular metabolism research

Agios is a biopharmaceutical company founded in 2008 in Cambridge, Massachusetts, focused on cellular metabolism and developing therapies for rare diseases, with a near-term focus on hemolytic and acquired anemias. Its first rare disease therapy was approved by the FDA for hemolytic anemia in adults with pyruvate kinase (PK) deficiency, and it is developing mitapivat and AG-946.

Read more

clinical trialsdrug discovery and development